Butterfly Network, Inc.
NYSE:BFLYMedical - Devices
+$1.88 today
- Market cap
- $1.63B
- Beta
- 2.20
- P/E (TTM)
- -25.7
- EPS (TTM)
- -$0.30
Volume 4.78M
Average 4.92M
BFLY Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Butterfly Network, Inc.NYSE: BFLY
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development declines year over year
Q1 FY2026 research & development of $9.54M fell 3.9% year over year, behind the -3.0% change in trailing-twelve-month research & development. Sequentially, it rose 2.3% from the prior quarter. Over 3 fiscal years it compounded at -25.6% a year.
Context
- Research & development amounted to 37.1% of revenue in FY2025, down 8.9 pp from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -3.9% toward the trailing-twelve-month pace of -3.0%.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 36.26M USD
- Year-over-year change
- -4.1%
- 4-year CAGR
- -16.5%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 36.26M | -4.1% |
| FY2024 | 2024-12-31 | 37.8M | -32.0% |
| FY2023 | 2023-12-31 | 55.62M | -36.8% |
| FY2022 | 2022-12-31 | 88.04M | +18.2% |
| FY2021 | 2021-12-31 | 74.46M | — |
Research & Development vs competitors
How BFLY compares with its peers on the latest reported figures
- Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -3.0% is the 4th highest of 7, against a peer median of -7.4%.
- Research & development amounts to 34.9% of revenue for BFLY, versus a peer median of 12.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $254.4M USD | -28.3% | -3.5% | 284.6% | |
| LTM Mar 2026 | $87.86M USD | -27.1% | -20.4% | 54.9% | |
| LTM Mar 2026 | €85.57M EUR | +12.6% | -6.7% | 54.7% | |
| LTM Mar 2026 | $61.4M USD | -16.9% | +5.2% | 7.4% | |
| LTM Mar 2026 | $55.69M USD | +11.9% | +23.1% | 17.4% | |
| LTM Mar 2026 | $35.88M USD | -3.0% | -25.6% | 34.9% | |
| LTM Mar 2026 | $17.11M USD | +2.1% | +8.6% | 8.3% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding BFLY) | — | -7.4% | +0.8% | 12.8% | |
Competitors are the stored peer set for BFLY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 62.57M | 73.39M | 65.9M | 82.06M | 97.61M |
| Cost of Revenue | 45.51M | 33.93M | 49.04M | 33.23M | 51.88M |
| Gross Profit | 17.05M | 39.46M | 16.86M | 48.83M | 45.73M |
| Gross Margin | 27.3% | 53.8% | 25.6% | 59.5% | 46.9% |
| Research & Development | 74.46M | 88.04M | 55.62M | 37.8M | 36.26M |
| Selling, General & Admin | 135.32M | 144.44M | 106.85M | 85.44M | 85.11M |
| Operating Expenses | 209.78M | 232.48M | 162.47M | 123.24M | 132.15M |
| Depreciation & Amortization | 2.09M | 5.94M | 10.57M | 10.34M | 8.08M |
| EBITDA | (29.55M) | (162.74M) | (123.04M) | (60.92M) | (67.38M) |
| EBITDA Margin | -47.2% | -221.8% | -186.7% | -74.2% | -69.0% |
| Operating Income | (192.73M) | (193.02M) | (145.61M) | (74.41M) | (86.42M) |
| Operating Margin | -308.0% | -263.0% | -221.0% | -90.7% | -88.5% |
| Interest Income | 2.57M | 3.38M | 7.45M | 5.02M | 5.91M |
| Interest Expense | 651K | 2K | 0 | 1.26M | 1.49M |
| Other Income / Expenses | 160.44M | 24.34M | 11.99M | 1.89M | 9.46M |
| Income Before Tax | (32.29M) | (168.68M) | (133.62M) | (72.52M) | (76.95M) |
| Pre-Tax Margin | -51.6% | -229.8% | -202.8% | -88.4% | -78.8% |
| Income Tax Expense | 121K | 42K | 82K | (32K) | 110K |
| Net Income | (32.41M) | (168.72M) | (133.7M) | (72.49M) | (77.06M) |
| Net Margin | -51.8% | -229.9% | -202.9% | -88.3% | -79.0% |
| EPS (Basic) | (0.19) | (0.84) | (0.65) | (0.34) | (0.31) |
| EPS (Diluted) | (0.19) | (0.84) | (0.65) | (0.34) | (0.31) |
| Weighted Avg Shares | 173.81M | 199.85M | 205.39M | 211.68M | 247.12M |
| Weighted Avg Shares (Diluted) | 173.81M | 199.85M | 205.39M | 211.68M | 247.12M |
Butterfly Network, Inc.
NYSE:BFLY
Intrinsic Alpha fair value
Locked
Current Price
$6.08
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.